Sagimet Biosciences jobs and careers

7Open roles

$370kHighest listed base pay

About Sagimet Biosciences

Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways.

Founded in 2007 by Lucas Pelkmans and Urs Greber.

Biopharma Biotechnology Therapeutics

Founded: 2007
Employees: 11 to 50
Total funding: $406.2M

Leadership

The top of Sagimet Biosciences's org chart, with how many people report into each leader.

David Happel

CEO & Director

12 reports

Anthony Rimac

CFO

2 reports

Elizabeth Rozek

General Counsel & Chief Compliance Officer

Marie O’Farrell

SVP of Research & Development

3 reports

Thierry Chauche

Chief Financial Officer

Andreas Grauer

Chief Medical Officer

Charlie Maddox

Senior Director, IT

Robert D'Urso

Senior Vice President New Products

Board

Beth Seidenberg

Chair

Richard Rodgers

Director

Jinzi J. Wu

Director

Elizabeth Grammer

Director

Elizabeth J. Parks

Scientific Advisor

Scott Friedman

Scientific Advisor

About Sagimet Biosciences

Leadership

Board

Open roles at Sagimet Biosciences 7